SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Keegan DL, Rajput AH. Drug induced dystonia tarda: Treatment with 1-dopa. Dis. Nerv. Syst. 1973; 34: 167169.
  • 2
    Burke RE, Fahn S, Jankovic J et al. Tardive dystonia: Late-onset and persistent dystonia caused by antipsychotic drugs. Neurology 1982; 32: 13351346.
  • 3
    Inada T, Yagi G, Kamijima K et al. A statistical trial of subclassification for tardive dyskinesia. Acta Psychiatr. Scand. 1990; 82: 404407.
  • 4
    Sachdev P. Risk factors for tardive dystonia: A case-control comparison with tardive dyskinesia. Acta Psychiatr. Scand. 1993; 88: 98103.
  • 5
    Raja M. Managing antipsychotic-induced acute and tardive dystonia. Drug Saf. 1998; 19: 5772.
  • 6
    Ujike H, Akiyama K, Otsuki S. D-2 but not D-1 dopamine agonists produce augmented behavioral response in rats after subchronic treatment with methamphetamine or cocaine. Psychopharmacology (Berl) 1990; 102: 459464.
  • 7
    Ujike H. Stimulant-induced psychosis and schizophrenia: The role of sensitization. Curr. Psychiatry Rep. 2002; 4: 177184.
  • 8
    LeWitt PA. Dystonia caused by drugs. In : TsuiJKC, KingJ, CalneDB (eds). Handbook of Dystonia. Marcel Dekker, New York, 1995; 227240.
  • 9
    Duggal HS. Cocaine use as a risk factor for ziprasidone-induced acute dystonia. Gen. Hosp. Psychiatry 2007; 29: 278279.
  • 10
    Fines RE, Brady EWJ, Debehnke DJ. Cocaine-associated dystonic reaction. Am. J. Emerg. Med. 1997; 15: 513515.
  • 11
    Gatalano G, Gatalano MC, Rodriguez R. Dystonia associated with crack cocaine use. South Med. J. 1997; 90: 10501052.
  • 12
    Van Harten PN, Van Trier JC, Horwitz EH, Matroots GE, Hoek HW. Cocaine as a risk factor for neuroleptic-induced acute dystonia. J. Clin. Psychiatry 1998; 59: 128130.
  • 13
    Chao AK, Kumagai Y. Metabolism of amphetamine and other arylisopropylamines. In : ChaoAK, SegalDS (eds). Amphetamine and Its Analogs. Academic Press, San Diego, CA, 1994; 4377.
  • 14
    Sadock BJ, Sadock VA. Kaplan and Sadock's Synopsis of Psychiatry, 9th edn. Lippincott Williams & Wilkins, Philadelphia, PA, 2003.
  • 15
    Lehman AF, Lieberman JA, Dixon LB et al. Work Group on Schizophrenia: Practice Guideline for the Treatment of Patients with Schizophrenia, 2nd edn. American Psychiatric Association, Washington, 2004.
  • 16
    Yoshida K, Higuchi H, Hishikawa Y. Marked improvement of tardive dystonia after replacing haloperidol with risperidone in a schizophrenic patient. Clin. Neuropharmacol. 1998; 21: 6869.
  • 17
    Wolf ME, Koller WC. Tardive dystonia: Treatment with trihexyphenidyl. J. Clin. Psychopharmacol. 1985; 5: 247248.
  • 18
    Marsalek M. Tardive drug-induced extrapyramidal syndromes. Pharmacopsychiatry 2000; 33 (Suppl. 1): 1433.
  • 19
    Thaker GK, Nguyen JA, Strauss ME, Jacobson R, Kaup BA, Tamminga CA. Clonazepam treatment of tardive dyskinesia: A practical GABAmimetic strategy. Am. J. Psychiatry 1990; 147: 445451.
  • 20
    Blake LM, Marks RC, Nierman P, Luchins DJ. Clozapine and clonazepam in tardive dystonia. J. Clin. Psychopharmacol. 1991; 11: 268269.
  • 21
    Shapleske J, Mickay AP, McKenna PJ. Successful treatment of tardive dystonia with clozapine and clonazepam. Br. J. Psychiatry 1996; 168: 516518.